UniProt ID | RIR2B_HUMAN | |
---|---|---|
UniProt AC | Q7LG56 | |
Protein Name | Ribonucleoside-diphosphate reductase subunit M2 B | |
Gene Name | RRM2B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 351 | |
Subcellular Localization | Cytoplasm. Nucleus. Translocates from cytoplasm to nucleus in response to DNA damage. | |
Protein Description | Plays a pivotal role in cell survival by repairing damaged DNA in a p53/TP53-dependent manner. Supplies deoxyribonucleotides for DNA repair in cells arrested at G1 or G2. Contains an iron-tyrosyl free radical center required for catalysis. Forms an active ribonucleotide reductase (RNR) complex with RRM1 which is expressed both in resting and proliferating cells in response to DNA damage.. | |
Protein Sequence | MGDPERPEAAGLDQDERSSSDTNESEIKSNEEPLLRKSSRRFVIFPIQYPDIWKMYKQAQASFWTAEEVDLSKDLPHWNKLKADEKYFISHILAFFAASDGIVNENLVERFSQEVQVPEARCFYGFQILIENVHSEMYSLLIDTYIRDPKKREFLFNAIETMPYVKKKADWALRWIADRKSTFGERVVAFAAVEGVFFSGSFAAIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFQYLVNKPSEERVREIIVDAVKIEQEFLTEALPVGLIGMNCILMKQYIEFVADRLLVELGFSKVFQAENPFDFMENISLEGKTNFFEKRVSEYQRFAVMAETTDNVFTLDADF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
17 | Methylation | AGLDQDERSSSDTNE CCCCCCCCCCCCCCH | 50.56 | 115492913 | |
18 | Phosphorylation | GLDQDERSSSDTNES CCCCCCCCCCCCCHH | 31.95 | 25849741 | |
19 | Phosphorylation | LDQDERSSSDTNESE CCCCCCCCCCCCHHH | 38.15 | 25159151 | |
20 | Phosphorylation | DQDERSSSDTNESEI CCCCCCCCCCCHHHH | 50.10 | 29743597 | |
22 | Phosphorylation | DERSSSDTNESEIKS CCCCCCCCCHHHHHC | 42.72 | 23927012 | |
25 | Phosphorylation | SSSDTNESEIKSNEE CCCCCCHHHHHCCCC | 46.84 | 24275569 | |
28 (in isoform 5) | Ubiquitination | - | 43.08 | 21906983 | |
28 (in isoform 1) | Ubiquitination | - | 43.08 | 21906983 | |
28 | Ubiquitination | DTNESEIKSNEEPLL CCCHHHHHCCCCCHH | 43.08 | 21906983 | |
29 | Phosphorylation | TNESEIKSNEEPLLR CCHHHHHCCCCCHHH | 55.95 | 24275569 | |
41 (in isoform 4) | Ubiquitination | - | 31.93 | 21906983 | |
72 | Phosphorylation | TAEEVDLSKDLPHWN CHHHCCCCCCCCCHH | 21.47 | 19015526 | |
92 (in isoform 6) | Phosphorylation | - | 2.07 | 28985074 | |
97 | Phosphorylation | SHILAFFAASDGIVN HHHHHHHHHHCCCCC | 10.29 | - | |
100 | Ubiquitination | LAFFAASDGIVNENL HHHHHHHCCCCCHHH | 46.22 | 22817900 | |
101 | Phosphorylation | AFFAASDGIVNENLV HHHHHHCCCCCHHHH | 24.21 | - | |
114 (in isoform 3) | Ubiquitination | - | 33.45 | 21906983 | |
114 (in isoform 2) | Ubiquitination | - | 33.45 | 21906983 | |
114 | Ubiquitination | LVERFSQEVQVPEAR HHHHHHHHCCCCCHH | 33.45 | 22817900 | |
115 | Ubiquitination | VERFSQEVQVPEARC HHHHHHHCCCCCHHH | 5.57 | 22817900 | |
116 (in isoform 2) | Ubiquitination | - | 44.27 | 21906983 | |
116 | Ubiquitination | ERFSQEVQVPEARCF HHHHHHCCCCCHHHC | 44.27 | 22817900 | |
128 | Ubiquitination | RCFYGFQILIENVHS HHCCCCHHHEECHHH | 3.80 | 27667366 | |
166 (in isoform 1) | Ubiquitination | - | 42.59 | 21906983 | |
166 | Ubiquitination | IETMPYVKKKADWAL HHHCHHHHHHHHHHH | 42.59 | 22817900 | |
167 | Ubiquitination | ETMPYVKKKADWALR HHCHHHHHHHHHHHH | 43.05 | 22817900 | |
168 | Ubiquitination | TMPYVKKKADWALRW HCHHHHHHHHHHHHH | 45.95 | 22817900 | |
168 (in isoform 1) | Ubiquitination | - | 45.95 | 21906983 | |
180 | Ubiquitination | LRWIADRKSTFGERV HHHHHHCCCCCCHHH | 55.16 | 27667366 | |
218 | Phosphorylation | RGLMPGLTFSNELIS CCCCCCCEECHHHHH | 30.82 | 20068231 | |
225 | Phosphorylation | TFSNELISRDEGLHC EECHHHHHCCCCCCC | 46.43 | 24719451 | |
238 | Ubiquitination | HCDFACLMFQYLVNK CCHHHHHHHHHHHCC | 1.66 | 22817900 | |
239 | Ubiquitination | CDFACLMFQYLVNKP CHHHHHHHHHHHCCC | 2.52 | 22817900 | |
240 | Ubiquitination | DFACLMFQYLVNKPS HHHHHHHHHHHCCCC | 19.38 | 22817900 | |
252 | Ubiquitination | KPSEERVREIIVDAV CCCHHHHHHHHHHHH | 35.30 | 27667366 | |
268 | Ubiquitination | IEQEFLTEALPVGLI HCHHHHHHHCCCCHH | 50.81 | 22817900 | |
274 (in isoform 2) | Ubiquitination | - | 2.89 | 21906983 | |
274 | Ubiquitination | TEALPVGLIGMNCIL HHHCCCCHHCHHHHH | 2.89 | 21963094 | |
320 | Ubiquitination | ENISLEGKTNFFEKR HHCCCCCCCCHHHHH | 30.81 | 22817900 | |
326 | Acetylation | GKTNFFEKRVSEYQR CCCCHHHHHHHHHHH | 53.60 | 11372325 | |
326 (in isoform 1) | Ubiquitination | - | 53.60 | 21906983 | |
326 | Ubiquitination | GKTNFFEKRVSEYQR CCCCHHHHHHHHHHH | 53.60 | 21963094 | |
329 | Phosphorylation | NFFEKRVSEYQRFAV CHHHHHHHHHHHHHH | 34.32 | 28857561 | |
331 | Phosphorylation | FEKRVSEYQRFAVMA HHHHHHHHHHHHHEE | 9.47 | - | |
392 | Ubiquitination | ------------------------------------------------ ------------------------------------------------ | 22817900 | ||
398 | Ubiquitination | ------------------------------------------------------ ------------------------------------------------------ | 21963094 | ||
401 | Phosphorylation | --------------------------------------------------------- --------------------------------------------------------- | 27251275 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RIR2B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RIR2B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
P53_HUMAN | TP53 | physical | 12615712 | |
MDM2_HUMAN | MDM2 | physical | 19015526 | |
ATM_HUMAN | ATM | physical | 19015526 | |
RIR2B_HUMAN | RRM2B | physical | 25416956 | |
RIR2_HUMAN | RRM2 | physical | 26186194 | |
SHIP2_HUMAN | INPPL1 | physical | 26186194 | |
RIR2_HUMAN | RRM2 | physical | 28514442 | |
SHIP2_HUMAN | INPPL1 | physical | 28514442 | |
TPM2_HUMAN | TPM2 | physical | 28514442 | |
JIP4_HUMAN | SPAG9 | physical | 28514442 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
612075 | Mitochondrial DNA depletion syndrome 8A (MTDPS8A) |
612075 | Mitochondrial DNA depletion syndrome 8B (MTDPS8B) |
613077 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5 (PEOA5) |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00242 | Cladribine |
loading...